Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy

Roberta BurnelliPediatric Oncology Hematology “Lalla Seragnoli”, Policlinico S.Orsola-Malpighi, Bologna, Italy; Correspondence[email protected]

Simona RinieriPediatric Onco-Hematology Unit, Azienda Ospedaliero-Universitaria Sant’Anna di Ferrara, Ferrara, Italy;

Roberto RondelliPediatric Oncology Hematology “Lalla Seragnoli”, Policlinico S.Orsola-Malpighi, Bologna, Italy;

Alessandra TodescoClinic of Pediatric Hemato-Oncology, Department of Women’s and Children’s Health, University of Padova, Padova, Italy;

Maurizio BianchiDivision of Pediatric Onco-Hematology, Regina Margherita Children’s Hospital, Torino, Italy;

Alberto GaraventaOncology Unit, Istituto G.Gaslini, Genova, Italy;

Marco ZeccaPediatric Haematology/Oncology, Fondazione IRCCS Policlinico “San Matteo”, Pavia, Italy;

Paolo IndolfiPediatric Oncology Service, Pediatric Department, Second University of Naples, Napoli, Italy;

Valentino ConterClinica Pediatrica, Università di Milano-Bicocca, Azienda Ospedaliera San Gerardo, Monza, Italy;

Nicola SantoroDivision of Pediatric Hematology Oncology, Department of Pediatrics, Bari, Italy;

Maurizio AricòDepartment of Pediatric Hematology Oncology, Azienda Ospedaliero Universitaria A. Meyer Children Hospital, Firenze, Italy;

Simone CesaroPediatric Hematology-Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy;

Salvatore D’amicoPediatric Hematology-Oncology, - Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele, Catania, Italy;

Piero FarruggiaDepartment of Oncology, Pediatric Hematology and Oncology Unit, A.R.N.A.S. Ospedali Civico Di Cristina e Benfratelli, Palermo, Italy;

Raffaela De SantisUnit of Pediatrics, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy;

Franco LocatelliDipartimento di Oncoematologia Pediatrica, Ospedale Bambino Gesù, IRCCS Roma, Rome, Italy;

Stefano A. PileriChair of Pathology and Unit of Haematopathology, Department of Haematology and Oncological Sciences “L. and A. Seràgnoli”, Bologna University, Bologna, Italy;

Giovanni ScarzelloRadiation therapy Department, IOV-IRCCS, Padova, Italy;

Maurizio MascarinS.S. Radioterapia Pediatrica e Area Giovani, IRCCS, Centro di Riferimento Oncologico Aviano, Pordenone, Italy;

Vico VecchiDepartment of Pediatrics, Pediatric Oncology Unit, “Infermi” Hospital, Rimini, Italy

& On behalf of AIEOP (Italian Association of Pediatric Hematology and Oncology) and Pediatric Hodgkin’s Lymphoma working Group show all

Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy

ICMJE Form for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy

ICMJE Form for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date